A clinical study to evaluate the efficacy and safety of mukulpure in treating the acne.

Not Applicable

Completed

• Registration Number: CTRI/2014/07/004796
• Lead Sponsor: VIdya Herbs

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2014-09-24
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

•Both Male / Female of age between 18-50 yrs

•Facial acne, with:

1.Inflammatory facial lesions (papules/pustules/nodules/cysts)

2.Non inflammatory facial lesions if open (blackhead) and if closed (whitehead) comedones

3.Mild to moderate acne with nodular abcesses, extensive lesions

•Willing to give written informed consent along with audio, video recording

Exclusion Criteria

•Patient not willing to comply with the study procedure

•Females who are pregnant or breast-feeding

•Skin diseases other than acne vulgaris

•Use of other topical or systemic treatments for acne

•Other significant medical conditions or clinically significant abnormal laboratory test results

•History of alcoholism or substance abuse and any other liver abnormalities

•Conditions in the opinion of the investigator make the patient unsuitable to participate in the study.

•History of Hormone-sensitive condition such as breast cancer, uterine cancer, ovarian cancer, endometriosis, or uterine fibroids

•Patients under medication with contraceptive pills, Diltiazem, Anticoagulant and Propranolol.

•History of hypothyroidism or hyperthyroidism

•History of HIV

•Participation in another trial within 3 months prior to informed consent

•Certain medications that may interfere with the study medication (these will be identified by the study doctor).

Study & Design

• Study Type: Interventional
• Study Design: Not specified